We also showed that HO-1 is further implicated in PCa, demonstrating that endogenous HO-1 inhibits bone-derived prostate cancer cell migration, invasion, and proliferation [4] and negatively modulates the expression of pro-inflammatory and pro-angiogenic genes. The gene discussed is HMOX1; the disease is prostate carcinoma.